InvestLog
TSHA Taysha Gene Therapies, Inc. logo

TSHA Taysha Gene Therapies, Inc.

Healthcare
$5.59+1.82%ClosedMarket Cap: $1.40B

As of 2026-05-26

Institutional Ownership Summary

Investors Holding

202

13F Shares

268,917,357

Ownership %

76.1%

New Positions

66

Increased Positions

129

Closed Positions

24

Reduced Positions

44

ETF Exposure
ETF SymbolETF NameShares HeldWeight %
PTHInvesco Dorsey Wright Healthcare Momentum ETF356,8211.29%
IBRNiShares Neuroscience and Healthcare ETF12,3691.09%
SBIOALPS Medical Breakthroughs ETF222,9860.74%
BBCVirtus Biotech Clinical Trials ETF47,0950.58%
XBI5,638,9110.33%
DWASInvesco Dorsey Wright SmallCap Momentum ETF278,6770.33%
LABUDirexion Daily S&P Biotech Bull 3X ETF282,1710.24%
IWCiShares Micro-Cap ETF556,5510.19%
IJE556,5510.19%
VFMO318,5460.14%
OMFSInvesco Russell 2000 Dynamic Multifactor ETF82,9800.14%
KOMPState Street SPDR S&P Kensho New Economies Composite ETF598,7590.11%
IBBQInvesco Nasdaq Biotechnology ETF16,1090.09%
IBBiShares Biotechnology ETF1,672,1800.09%
AVSCX18,9550.09%
FESMFidelity Enhanced Small Cap ETF729,2810.07%
BIBProShares - Ultra Nasdaq Biotechnology12,2530.07%
VTWG202,5060.06%
NLO1,793,9050.06%
IWOiShares Russell 2000 Growth ETF1,793,9050.06%